Pay in 4 interest-free payments of $5.54 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Payers dont consider this sustainable, as it crowds out their ability to cover drugs in other therapeutic categories
The interplay between CKD, sudden cardiac death, and ventricular arrhythmias
Get access for free Inside the GLP-1 Gold Rush: Eli Lilly CEO on New Breakthroughs, Addiction & Mental Health, Pricing Pricing, Profitability, and Accessibility of Glp-1 Drugs The conversation focuses on Eli Lilly's efforts to manage the pricing and profitability of GLP-1 drugs while also aiming to increase their accessibility for patients through insurance coverage
GLP-1 outcomes: What weve learned and where payers need to focus next GLP-1s continue to be a focus in the healthcare industry
Retatrutide for Weight Loss Retatrutide is still being studied, but the numbers are eye-catching
US$ 21.92
US$ 20.78
US$ 26.45
US$ 26.80
US$ 27.10
US$ 22.15
US$ 29.77
US$ 29.95
